Characterization of a Trypanosoma rangeli Strain of Colombian Origin [PDF]
Memorias do Instituto Oswaldo Cruz, 1997 A Colombian strain of Trypanosoma rangeli was characterized by analyzing its behaviour in different axenic and cellular culture, its infection rate and the histopathological lesions produced in experimental animals.
C Zuñiga +4 more
doaj +7 more sources
Action of Trypanosoma rangeli in infections with virulent Trypanosoma cruzi populations [PDF]
Memorias do Instituto Oswaldo Cruz, 2003 In experimental murine infections with Trypanosoma rangeli it has been observed development immune response to Trypanosoma cruzi. The aim of the present work was to analyze the result of antigenic stimuli and the protective effect with T.
MT Paláu +3 more
doaj +4 more sources
Rhodnius stali: new vector infected by Trypanosoma rangeli (Kinetoplastida, Trypanosomatidae) [PDF]
Revista da Sociedade Brasileira de Medicina Tropical, 2017 INTRODUCTION Rhodnius stali infection by Trypanosoma rangeli is reported in this study for the first time. METHODS The triatomines were collected from the campus of the Federal University of Acre in Rio Branco, Acre, Brazil.
Gabriela Vieira de Souza Castro +6 more
doaj +3 more sources
Metalloproteases in Trypanosoma rangeli-infected Rhodnius prolixus [PDF]
Memórias do Instituto Oswaldo Cruz, 1999 Protease activities in the haemolymph and fat body in a bloodsucking insect, Rhodnius prolixus, infected with Trypanosoma rangeli, were investigated. After SDS-polyacrylamide gel electrophoresis containing gelatin as substrate, analysis of zymograms performed on samples of different tissues of controls and insects inoculated or orally infected with ...
Feder, D +3 more
core +8 more sources
La región intergénica del gen H2A apoya las subpoblaciones KP1(-) y KP1(+) de Trypanosoma rangeli [PDF]
Biomédica: revista del Instituto Nacional de Salud, 2007 Introducción. Con base en la amplificación del ADN de los minicírculos del cinetoplasto y de los genes miniexón, Trypanosoma rangeli ha sido clasificado en las subpoblaciones KP1(-) y KP1(+). Objetivo.
Brian Alejandro Suárez +2 more
doaj +2 more sources
Vaccination with epimastigotes of different strains of Trypanosoma rangeli protects mice against Trypanosoma cruzi infection [PDF]
Memorias do Instituto Oswaldo Cruz, 2008 In our laboratory, we have developed a model of vaccination in mice with Trypanosoma rangeli, a non-pathogenic parasite that shares many antigens with Trypanosoma cruzi. The vaccinated mice were protected against infection with virulent T. cruzi.
Beatriz Basso +2 more
doaj +3 more sources
Differential in vitro activity of the DNA topoisomerase inhibitor idarubicin against Trypanosoma rangeli and Trypanosoma cruzi [PDF]
Memorias do Instituto Oswaldo Cruz, 2012 In this study the effect of eight DNA topoisomerase inhibitors on the growth Trypanosoma rangeli epimastigotes in cell culture was investigated. Among the eight compounds tested, idarubicin was the only compound that displayed promising trypanocidal ...
Momodou Jobe +14 more
doaj +2 more sources
Trypanosoma rangeli Tejera 1920
, 2018 Published as part of Molinari, Jesús & Moreno, S. Andrea, 2018, The correct subgeneric name of Trypanosoma rangeli Tejera, 1920 (Euglenozoa: Trypanosomatidae), a human-infective endoparasite of neotropical mammals, pp.
Molinari, Jesús, Moreno, S. Andrea
openaire +3 more sources
Trypanosoma (Herpetosoma) rangeli Tejera, 1920: an updated review
Memorias do Instituto Oswaldo Cruz, 2003 Trypanosoma rangeli, a parasite generally considered non-pathogenic for man, is the second species of human trypanosome to be reported from the New World. The geographical distribution of T. rangeli often overlaps with that of T.
Felipe Guhl, Gustavo Adolfo Vallejo
doaj +2 more sources
Identification of a type I nitroreductase gene in non-virulent Trypanosoma rangeli. [PDF]
Mem Inst Oswaldo Cruz, 2017 Trypanosomatid type I nitroreductases (NTRs), i.e., mitochondrial enzymes that metabolise nitroaromatic pro-drugs, are essential for parasite growth, infection, and survival.
Montenegro M +7 more
europepmc +2 more sources